Answers are grounded in this paper and cite their sources.
Patch tests (PTs) are recommended to identify the culprit drug in non-immediate cutaneous adverse drug reactions (NICADRs). We recently reported that, in patients with NICADRs, a unique reading of PTs at day (D)2 compared with an additional second late reading at D4 missed almost half (45.3%) of the positive PTs.
No takes yet. Share an insight, caveat, or question.
Matei et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: